Consumer Cyclical
Live Price
Offline$43.77
+2.70% today
1Y Change
+40.49%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 240 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TriMas Corporation (TRS) is a Consumer Cyclical stock with a market cap of $1.45B and listed on NASDAQ. The stock last traded around $43.77 and up 40.5% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of -30.2%, EPS growth of +395.0%, a dividend yield of 0.4%. What stands out right now is revenue -30.2%, EPS +395.0%, free cash flow +439.0% with operating margin 6.2% and ROIC 2.1%. The dividend is present but secondary, with a yield around 0.4%. Valuation is more restrained than many high-expectation growth names at P/E 1.6 and price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TRS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TRS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TRS Max Drawdown
-22.34%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TRS and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$857.1M
-3.0% YoY
FY Net Income
$57.3M
-13.4% YoY
Free Cash Flow
$89.2M
+235.1% YoY
Revenue Growth
-30.2%
EPS Growth
+395.0%
Gross Margin
22.8%
Net Margin
104.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 646M | 925M | 894M | 884M | 857M |
| Gross Profit | 138M | 185M | 195M | 194M | 202M |
| Operating Income | 9M | 53M | 77M | 82M | 105M |
| EBITDA | 99M | 115M | 124M | 155M | 137M |
| Net Income | 120M | 24M | 40M | 66M | 57M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 30M | 23M | 35M | 112M | 141M |
| Total Assets | 1.5B | 1.3B | 1.3B | 1.3B | 1.3B |
| Total Liabilities | 779M | 657M | 659M | 653M | 673M |
| Shareholder Equity | 706M | 667M | 683M | 652M | 631M |
| Total Debt | 505M | 443M | 443M | 444M | 446M |
| Net Debt | 475M | 420M | 408M | 332M | 305M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
134M
+85.0% YoY
Capital Expenditures
45M
+2.0% YoY
Free Cash Flow
89M
+235.1% YoY
Key ratios
Gross Margin
22.8%
Operating Margin
6.2%
Net Margin
104.7%
ROE
101.1%
Debt / Equity
0.03x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.